I know. Very disheartening. Even a little bit of solid buying could push this over $10 pretty easily. Jeez at least it should be over it's IPO price you would think after 2.5 years.
Yes. It is consolidating nicely at this price and the bands are tight. A range break should carry this over $5 in a hurry. Lots of news packed into the second half of the year. Either $16 or $2 but I like the risk/return down at this level.
Let the rally continue. Why take profits now?
I wish we knew how the main rivipansel enrollment is going since last summer. In the fall, PFE used it with Halo's Enhanze in its phase one clinical. So much damn potential, so little news.
It's going to run again this year. Looking for $16-$20
Hee hee. This was when ANTH was in the $60's pre reverse split days.
I'm looking for $20 this year.